Table 4.
Week 6 | Week 12 | Month 6 | Month 12 | |
---|---|---|---|---|
6MWD, ma | 9.5 (−14 to 35)d | 16.0 (−8 to 39)e | 26.0 (−3 to 51)e | 27.0 (−7 to 54)d |
BDIa | −0.54 (0.20)c | −0.66 (0.22)d | −0.51 (0.27)ns | −1.06 (0.36)d |
NT-proBNP, pg/mLb | −80 (−376 to 50)e | −74 (−339 to 37)d | −111 (−345 to 93)ns | |
WHO functional class | ||||
Improved | 4 (6) | 6 (9) | 11 (19) | 7 (29) |
Maintained | 61 (87) | 60 (87) | 45 (78) | 16 (67) |
Worsened | 5 (7) | 3 (4) | 2 (3) | 1 (4) |
Values presented as median (interquartile range), mean (SE), or n (%). 6MWD, 6-min walk distance; BDI, borg dyspnea index; NT-proBNP, N-terminal pro-B-type natriuretic peptide.
6MWD and BDI data for n = 70 (week 6), n = 68 (week 12), n = 55 (month 6), and n = 23 (month 12).
NT-proBNP data for n = 69 (week 6), n = 68 (week 12), and n = 24 (month 12).
P < 0.05.
P < 0.01.
P < 0.001.
ns, not significant.